Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

Your AI Is Only as Good as Your Inputs

Augustė Užuotaitė of Thermo Fisher Scientific feels the real innovation ahead is not just smarter software or technology. It is robust assay design, reagent chemistry, and consumables designed for automated workflows: stable at room temperature, tolerant to inhibitors, and consistent in multiplex performance. Don't miss this insightful August issue Thought Leader article. The post Your AI Is Only…

Your AI Is Only as Good as Your Inputs

The article emphasizes the importance of high-quality inputs in AI and automation systems used in genetic analysis, particularly in real-time PCR (qPCR) assays. While AI and automation offer numerous benefits, including reduced manual variability and faster data generation, they can also amplify small issues if the foundational consumables, such as master mixes, primers, probes, and plates, are inconsistent.

The article stresses that labs should prioritize analytically validated reagents and consumables to ensure the reliability of their automated workflows. Without a stable foundation in consumables and chemistry, the advanced capabilities of AI and automation may introduce new errors and hinder reproducibility, which is crucial for maintaining credibility in genetic analysis.

Brief written by urgent.news from GEN Biotechnology's own syndicated text. Machine-written — may contain errors; check the original before relying on it.

Read the original at genengnews.com →

More in Health & Medicine

California Bill Targets Toxic Chemicals in Disposable Diapers

The bill would require manufacturers to list all intentionally added ingredients online and on diaper packaging by 2029.

  • Assembly Bill 1901 aims to require diaper manufacturers to disclose all added chemicals by 2028.
  • Consumer safety groups support the bill, while manufacturers oppose it.
  • Violations could result in penalties up to $10,000 per day.

Eight biotech companies in Melbourne you should know about

Discover 8 biotech companies in Melbourne, ranging from commercial to preclinical-stage companies, advancing promising technologies.

  • Telix Pharmaceuticals leads in radiopharmaceuticals with Illuccix for prostate cancer
  • Ena Respiratory develops INNA-051 to combat viral respiratory infections
  • Mesoblast receives FDA approval for Ryoncil to treat acute graft vs host disease in children

More from Monday 17 August →